---
provider: claude_code
model: claude-haiku-5-5, claude-sonnet-5-5
cached: false
start_time: '2026-10-23T21:16:55.341261'
end_time: '2026-10-23T21:18:29.247709'
duration_seconds: 93.91
template_file: templates/disease_pathophysiology_research.md
template_sha: "f452f0a9c7e3536175154b9683c45663f686f283"
template_variables:
  disease_name: Spermatogenic Failure X-linked 5
  mondo_id: MONDO:0859477
  category: Mendelian
  causal_genes: SSX1
  omim_id: OMIM:301099
  synonyms: SPGFX5; SSX1-related asthenoteratozoospermia
provider_config:
  timeout: 1800
  max_retries: 3
  parameters:
    allowed_domains: []
    claude_executable: claude
    skip_permissions: false
    allowed_tools:
    - WebSearch
    - WebFetch
    add_dirs: []
    timeout: 1800
    min_report_chars: 200
    extra_args: []
run_metadata:
  models_used:
  - claude-haiku-5-5
  - claude-sonnet-5-5
  web_search_requests: 4
  num_turns: 11
  total_cost_usd: 0.8280633
  session_id: 89c9b5bb-a581-5af1-a5aa-767b76668861
  stop_reason: end_turn
  permission_denials: 2
  denied_tools:
  - Bash
  assistant_text_blocks: 2
citation_count: 15
reference_validation:
  total_references: 5
  verified: 3
  not_found: 0
  unverifiable: 2
  confabulation_rate: 0.0
  relevance_assessed: 3
  on_topic: 2
  validator_version: 0.3.0
term_validation:
  total_terms: 11
  verified: 10
  not_found: 0
  obsolete: 0
  unverifiable: 1
  confabulation_rate: 0.0
  labels_checked: 5
  labels_matching: 1
  labels_mismatched: 3
  mislabelled_terms:
  - term_id: HP:0012206
    reported_labels:
    - Asthenozoospermia (reduced progressive motility)
    ontology_label: Abnormal sperm motility
  - term_id: HP:0012864
    reported_labels:
    - Teratozoospermia, including flagellar morphology defects (MMAF-like)
    ontology_label: Abnormal sperm morphology
  - term_id: CL:0000018
    reported_labels:
    - Suggested cell types are spermatid
    ontology_label: spermatid
  labels_variant: 1
  unresolvable_prefixes:
  - MGI
  needs_review: true
  adapter: 'ols:'
  validator_version: 0.4.5
---

## Question

# Disease Characteristics Research Template

## Target Disease
- **Disease Name:** Spermatogenic Failure X-linked 5
- **MONDO ID:** MONDO:0859477 (if available)
- **Causal gene(s):** SSX1
- **OMIM:** OMIM:301099
- **Synonyms:** SPGFX5; SSX1-related asthenoteratozoospermia
- **Category:** Mendelian

Many disease names are serial numbers ("... autosomal dominant 64", "... 26") that
do not say which gene the disease is about, and a similarly named disease with a
different gene is easy to research by mistake. Research the disease with the MONDO
ID and causal gene given above, and name its causal gene in your first paragraph.
If the name seems to point to a different gene or OMIM entry, follow the
identifiers above.

## Research Objectives

Please provide a comprehensive research report on **Spermatogenic Failure X-linked 5** covering all of the
disease characteristics listed below. This report will be used to populate a disease knowledge
base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, **suggested databases/resources** are listed. These are the first places
you should search for information on each topic.

---

### 1. Disease Information
> **Search first:** OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

- What is the disease? Provide a concise overview.
- What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
- What are the common synonyms and alternative names?
- Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

### 2. Etiology

- **Disease Causal Factors**: What are the primary causes? (genetic, environmental, infectious, mechanistic)
- **Risk Factors**:
  > **Search first:** PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
  - Genetic risk factors (causal variants, susceptibility loci, modifier genes)
  - Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
- **Protective Factors**:
  > **Search first:** PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
  - Genetic protective factors (protective variants, modifier alleles)
  - Environmental protective factors (diet, lifestyle, exposures that reduce risk)
- **Gene-Environment Interactions**: How do genetic and environmental factors interact to influence disease?
  > **Search first:** CTD, PubMed, PheGenI, GxE databases

### 3. Phenotypes
> **Search first:** HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide:
- **Phenotype type**: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities
  > For symptoms/signs: HPO, OMIM, Orphanet, PubMed
  > For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed
  > For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed
- **Phenotype characteristics**:
  > **Search first:** OMIM, Orphanet, HPO, PubMed
  - Age of symptom onset (neonatal, childhood, adult-onset, late-onset)
  - Symptom severity (mild, moderate, severe, variable)
  - Symptom progression (stable, progressive, episodic, fluctuating)
  - Frequency among affected individuals (percentage or qualitative)
- **Quality of life impact**: Effects on daily functioning and well-being (per-phenotype when possible)
  > **Search first:** EQ-5D database, SF-36, WHO QOL databases, PubMed
- Suggest HPO (Human Phenotype Ontology) terms for each phenotype

### 4. Genetic/Molecular Information

- **Causal Genes**: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)
  > **Search first:** OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
- **Pathogenic Variants**:
  - Affected genes (gene symbols, HGNC IDs)
    > **Search first:** OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
  - Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines)
    > **Search first:** ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
  - Variant type/class (missense, frameshift, nonsense, splice-site, structural)
  - Allele frequency in population databases
    > **Search first:** gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
  - Somatic vs germline origin
    > **Search first:** COSMIC (somatic), ClinVar, ICGC, TCGA
  - Functional consequences (loss of function, gain of function, dominant negative)
- **Modifier Genes**: Genes that modify disease severity or expression
- **Epigenetic Information**: DNA methylation, histone modifications, chromatin changes affecting disease
  > **Search first:** ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
- **Chromosomal Abnormalities**: Large-scale genetic changes (aneuploidy, translocations, inversions)
  > **Search first:** DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

### 5. Environmental Information

- **Environmental Factors**: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)
  > **Search first:** CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
- **Lifestyle Factors**: Behavioral factors (smoking, diet, exercise, alcohol consumption)
  > **Search first:** CDC databases, WHO, PubMed, NHANES
- **Infectious Agents**: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)
  > **Search first:** NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

### 6. Mechanism / Pathophysiology

**Present this section as an ordered causal chain first, then the detail below.**
Open with a numbered sequence of mechanistic steps running from the initiating
lesion (mutation, exposure, infection) to the clinical manifestation, one step per
line, each naming what it causes next. State the causal verb explicitly ("leads
to", "results in") and say where a step is inferred rather than demonstrated.
Where the mechanism branches, show the branch. The categories below are a
checklist of what to cover within those steps, not the organizing structure —
a step may draw on several of them, and a category may contribute to several
steps.

- **Molecular Pathways**: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)
  > **Search first:** KEGG, Reactome, WikiPathways, PathBank, BioCyc
- **Cellular Processes**: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)
  > **Search first:** Gene Ontology (GO), Reactome, KEGG, PubMed
- **Protein Dysfunction**: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)
  > **Search first:** UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
- **Metabolic Changes**: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)
  > **Search first:** KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
- **Immune System Involvement**: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)
  > **Search first:** ImmPort, Immunome Database, IEDB, Gene Ontology
- **Tissue Damage Mechanisms**: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)
  > **Search first:** PubMed, Gene Ontology, Reactome
- **Biochemical Abnormalities**: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)
  > **Search first:** BRENDA, UniProt, KEGG, OMIM, PubMed
- **Epigenetic Changes**: DNA methylation, histone modifications affecting gene expression in disease
  > **Search first:** ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
- **Molecular Profiling** (if available):
  - Transcriptomics/gene expression changes
    > **Search first:** GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
  - Proteomics findings
    > **Search first:** PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
  - Metabolomics signatures
    > **Search first:** MetaboLights, Metabolomics Workbench, HMDB, METLIN
  - Lipidomics alterations
    > **Search first:** LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
  - Genomic structural features
    > **Search first:** UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
- **Advanced Technologies** (if applicable):
  - Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity)
    > **Search first:** Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
  - Spatial transcriptomics findings
    > **Search first:** GEO, Spatial Research, Vizgen, 10x Genomics data
  - Multi-omics integration results
    > **Search first:** TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
  - Functional genomics screens (CRISPR, RNAi)
    > **Search first:** DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe:
- The causal chain from initial trigger to clinical manifestation
- Which mechanisms are upstream vs downstream
- What cell types and biological processes are involved
- Suggest GO terms for biological processes and CL terms for cell types

### 7. Anatomical Structures Affected

- **Organ Level**:
  - Primary organs directly affected
  - Secondary organ involvement (complications, secondary effects)
  - Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)
  > **Search first:** Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
- **Tissue and Cell Level**:
  - Specific tissue types affected (epithelial, connective, muscle, nervous)
  - Specific cell populations targeted (with Cell Ontology terms)
  > **Search first:** Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
- **Subcellular Level**:
  - Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)
  > **Search first:** Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
- **Localization**:
  - Specific anatomical sites (with UBERON terms)
    > **Search first:** FMA, Uberon, NeuroNames (for brain), SNOMED CT
  - Lateralization (unilateral, bilateral, asymmetric)
    > **Search first:** HPO, clinical literature, imaging databases

### 8. Temporal Development

- **Onset**:
  - Typical age of onset (congenital, pediatric, adult, geriatric)
  - Onset pattern (acute, subacute, chronic, insidious)
  > **Search first:** OMIM, Orphanet, HPO, PubMed
- **Progression**:
  - Disease stages (early, intermediate, advanced, end-stage)
    > **Search first:** Cancer Staging Manual (AJCC), WHO classifications, PubMed
  - Progression rate (rapid, slow, variable)
  - Disease course pattern (episodic, relapsing-remitting, progressive, stable)
  - Disease duration (self-limited, chronic lifelong)
  > **Search first:** Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
- **Patterns**:
  - Remission patterns (spontaneous, treatment-induced)
    > **Search first:** Clinical trial databases, disease registries, PubMed
  - Critical periods (time windows of vulnerability or opportunity for intervention)
    > **Search first:** PubMed, developmental biology databases, clinical guidelines

### 9. Inheritance and Population

- **Epidemiology**:
  - Prevalence (cases per 100,000 at given time)
  - Incidence (new cases per 100,000 per year)
  > **Search first:** Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
- **For Genetic Etiology**:
  - Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic)
    > **Search first:** OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
  - Penetrance (complete, incomplete, age-dependent)
    > **Search first:** ClinVar, OMIM, PubMed, ClinGen
  - Expressivity (variable, consistent)
    > **Search first:** OMIM, ClinVar, PubMed
  - Genetic anticipation (increasing severity in successive generations)
    > **Search first:** OMIM, PubMed (especially for repeat expansion disorders)
  - Germline mosaicism
    > **Search first:** ClinVar, OMIM, genetic counseling literature, PubMed
  - Founder effects (population-specific mutations)
    > **Search first:** gnomAD, population genetics databases, PubMed
  - Consanguinity role
    > **Search first:** OMIM, population studies, genetic counseling resources
  - Carrier frequency
    > **Search first:** gnomAD, carrier screening databases, GeneReviews, GTR
- **Population Demographics**:
  - Affected populations (ethnic or demographic groups with higher prevalence)
    > **Search first:** gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
  - Geographic distribution (endemic areas, regional variation)
    > **Search first:** WHO, CDC, GBD, Orphanet, geographic epidemiology databases
  - Geographic distribution of specific variants
  - Sex ratio (male:female)
    > **Search first:** Disease registries, OMIM, PubMed, epidemiological databases
  - Age distribution of affected individuals
    > **Search first:** CDC, disease registries, SEER, Orphanet

### 10. Diagnostics

- **Clinical Tests**:
  - Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays)
    > **Search first:** LOINC, LabTests Online, PubMed
  - Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers)
    > **Search first:** FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
  - Imaging studies (X-ray, CT, MRI, PET, ultrasound)
    > **Search first:** RadLex, DICOM, Radiopaedia, imaging databases
  - Functional tests (pulmonary function, cardiac stress tests)
    > **Search first:** LOINC, clinical guidelines, PubMed
  - Electrophysiology (EEG, EMG, ECG, nerve conduction studies)
    > **Search first:** LOINC, clinical neurophysiology databases, PubMed
  - Biopsy findings (histopathology, immunohistochemistry)
    > **Search first:** SNOMED CT, College of American Pathologists resources, PubMed
  - Pathology findings (microscopic examination)
    > **Search first:** SNOMED CT, Digital Pathology databases, PubMed
- **Genetic Testing**:
  > **Search first:** GTR (Genetic Testing Registry), GeneReviews, ClinGen
  - Overview of recommended genetic testing approach
  - Whole genome sequencing (WGS) utility
    > **Search first:** GTR, ClinVar, GEL (Genomics England), gnomAD
  - Whole exome sequencing (WES) utility
    > **Search first:** GTR, ClinVar, OMIM, GeneMatcher
  - Gene panels (which panels, which genes)
    > **Search first:** GTR, ClinVar, laboratory-specific databases
  - Single gene testing
    > **Search first:** GTR, ClinVar, OMIM, GeneReviews
  - Chromosomal microarray (CMA)
    > **Search first:** DECIPHER, ClinVar, dbVar, ECARUCA
  - Karyotyping
    > **Search first:** Chromosome Abnormality Database, ClinVar, cytogenetics resources
  - FISH
    > **Search first:** ClinVar, cytogenetics databases, PubMed
  - Mitochondrial DNA testing
    > **Search first:** MITOMAP, MSeqDR, ClinVar, GTR
  - Repeat expansion testing
    > **Search first:** GTR, ClinVar, repeat expansion databases, PubMed
- **Omics-Based Diagnostics** (if applicable):
  - RNA sequencing / transcriptomics
    > **Search first:** GEO, ArrayExpress, GTEx, RNA-seq databases
  - Proteomics
    > **Search first:** PRIDE, ProteomeXchange, FDA Biomarker database
  - Metabolomics
    > **Search first:** MetaboLights, Metabolomics Workbench, HMDB
  - Epigenomics
    > **Search first:** GEO, ENCODE, Roadmap Epigenomics, MethBase
  - Liquid biopsy
    > **Search first:** COSMIC, ClinVar, liquid biopsy databases, PubMed
- **Clinical Criteria**:
  - Standardized diagnostic criteria (DSM, ICD, society guidelines)
    > **Search first:** DSM-5, ICD-11, clinical society guidelines, UpToDate
  - Differential diagnosis (other conditions to rule out, with distinguishing features)
    > **Search first:** DynaMed, UpToDate, clinical decision support systems
- **Screening**:
  - Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening)
    > **Search first:** ACMG recommendations, CDC newborn screening, GTR

### 11. Outcome/Prognosis

- **Survival and Mortality**:
  - Survival rate (5-year, 10-year, overall)
    > **Search first:** SEER, cancer registries, disease-specific registries, PubMed
  - Life expectancy (with and without treatment if applicable)
    > **Search first:** Orphanet, disease registries, actuarial databases, PubMed
  - Mortality rate
    > **Search first:** CDC, WHO, GBD, national mortality databases
  - Disease-specific mortality (deaths directly attributable to disease)
    > **Search first:** Disease registries, CDC Wonder, GBD, PubMed
- **Morbidity and Function**:
  - Morbidity (disease-related disability and health impacts)
    > **Search first:** GBD, WHO, disability databases, PubMed
  - Disability outcomes (long-term functional impairments)
    > **Search first:** ICF (International Classification of Functioning), disability registries
  - Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools)
    > **Search first:** EQ-5D database, SF-36, PROMIS, PubMed
- **Disease Course**:
  - Complications (secondary problems: infections, organ failure, etc.)
    > **Search first:** ICD codes, disease registries, clinical databases, PubMed
  - Recovery potential (likelihood and extent of recovery, with vs without treatment)
    > **Search first:** Natural history studies, rehabilitation databases, PubMed
- **Prediction**:
  - Prognostic factors (age, disease severity, biomarkers, treatment response)
    > **Search first:** Prognostic models databases, clinical calculators, PubMed
  - Prognostic biomarkers (molecular markers predicting disease course)
    > **Search first:** FDA Biomarker database, PubMed, cancer prognostic databases

### 12. Treatment

- **Pharmacotherapy**:
  - Pharmacological treatments (drug names, drug classes, mechanisms of action)
    > **Search first:** DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
  - Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity)
    > **Search first:** PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
- **Advanced Therapeutics**:
  - Gene therapy (viral vectors, CRISPR, gene replacement, gene editing)
    > **Search first:** ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
  - Cell therapy (stem cell transplant, CAR-T, cellular therapeutics)
    > **Search first:** ClinicalTrials.gov, FDA cell therapy database, FACT standards
  - RNA-based therapies (ASOs, siRNA, mRNA therapies)
    > **Search first:** ClinicalTrials.gov, FDA approvals, PubMed
  - Targeted therapies (treatments directed at specific molecular targets)
    > **Search first:** My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
  - Immunotherapies (checkpoint inhibitors, monoclonal antibodies)
    > **Search first:** Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
- **Surgical and Interventional**:
  - Surgical interventions (types of surgery, timing, outcomes)
    > **Search first:** CPT codes, surgical registries, clinical guidelines, PubMed
- **Supportive and Rehabilitative**:
  - Supportive care (symptom management, pain control, nutrition)
    > **Search first:** Clinical guidelines, Cochrane Library, PubMed
  - Rehabilitation (physical therapy, occupational therapy, speech therapy)
    > **Search first:** Rehabilitation medicine databases, clinical guidelines, PubMed
- **Experimental**:
  - Experimental treatments in clinical trials (with NCT identifiers if available)
    > **Search first:** ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
- **Treatment Outcomes**:
  - Treatment response rates
    > **Search first:** Clinical trial databases, FDA reviews, systematic reviews, PubMed
  - Side effects and adverse events
    > **Search first:** FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
- **Treatment Strategy**:
  - Treatment algorithms (clinical pathways, decision trees)
    > **Search first:** Clinical practice guidelines, NCCN Guidelines, UpToDate
  - Combination therapies
    > **Search first:** ClinicalTrials.gov, treatment guidelines, PubMed
  - Personalized medicine approaches (genotype-guided treatment)
    > **Search first:** My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

### 13. Prevention

- **Prevention Levels**:
  - Primary prevention (preventing disease occurrence: vaccination, risk factor modification)
    > **Search first:** CDC, WHO, USPSTF recommendations, Cochrane Library
  - Secondary prevention (early detection and treatment: screening programs, early intervention)
    > **Search first:** USPSTF, CDC screening guidelines, WHO
  - Tertiary prevention (preventing complications in those with disease)
    > **Search first:** Clinical guidelines, disease management protocols, PubMed
- **Immunization**: Vaccine strategies (if applicable)
  > **Search first:** CDC vaccine schedules, WHO immunization, FDA vaccine database
- **Screening and Early Detection**:
  - Screening programs (population-based: newborn screening, cancer screening)
    > **Search first:** CDC screening programs, USPSTF, cancer screening databases
  - Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing)
    > **Search first:** ACMG recommendations, ACOG guidelines, GTR
  - Risk stratification (identifying high-risk individuals for targeted prevention)
    > **Search first:** Risk prediction models, clinical calculators, PubMed
- **Behavioral Interventions**: Lifestyle modifications to reduce risk
  > **Search first:** CDC, WHO, behavioral intervention databases, Cochrane Library
- **Counseling**: Genetic counseling (risk assessment, family planning guidance)
  > **Search first:** NSGC resources, ACMG guidelines, GeneReviews
- **Public Health**:
  - Public health interventions (sanitation, vector control, health education)
    > **Search first:** CDC, WHO, public health databases, PubMed
  - Environmental interventions (reducing environmental risk factors)
    > **Search first:** EPA databases, WHO environmental health, PubMed
- **Prophylaxis**: Preventive medications or procedures
  > **Search first:** Clinical guidelines, FDA approvals, PubMed

### 14. Other Species / Natural Disease

- **Taxonomy**: Species affected (with NCBI Taxon identifiers)
  > **Search first:** NCBI Taxonomy
- **Breed**: Specific breeds affected (with VBO identifiers if applicable)
  > **Search first:** VBO (Vertebrate Breed Ontology)
- **Gene**: Orthologous genes in other species (with NCBI Gene IDs)
  > **Search first:** NCBI Gene
- **Natural Disease**:
  - Naturally occurring disease in other species (companion animals, wildlife)
    > **Search first:** OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
  - Veterinary relevance and importance in animal health
    > **Search first:** OMIA, veterinary databases, PubMed
- **Comparative Biology**:
  - Comparative pathology (similarities and differences across species)
    > **Search first:** OMIA, comparative pathology databases, PubMed
  - Evolutionary conservation of disease mechanisms
    > **Search first:** HomoloGene, OrthoMCL, Alliance of Genome Resources
- **Transmission** (if applicable):
  - Zoonotic potential
    > **Search first:** CDC zoonotic diseases, WHO zoonoses, GIDEON
  - Cross-species susceptibility
    > **Search first:** NCBI Taxonomy, veterinary databases, PubMed

### 15. Model Organisms

- **Model Types**:
  - Model organism type (mammalian, invertebrate, cellular, in vitro)
    > **Search first:** Alliance of Genome Resources, model organism databases
  - Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs)
    > **Search first:** MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
  - Induced models (drug treatment, surgical intervention, environmental manipulation)
    > **Search first:** MGI, model organism databases, PubMed
- **Genetic Models**:
  - Types available (knockout, knock-in, transgenic, conditional, humanized)
    > **Search first:** MGI, IMPC, KOMP, EuMMCR, IMSR
- **Model Characteristics**:
  - Phenotype recapitulation (how well model reproduces human disease features)
    > **Search first:** Model organism databases, comparative studies, PubMed
  - Model limitations (aspects of human disease not captured)
    > **Search first:** Model organism databases, PubMed, review articles
- **Applications**:
  - Research applications (what aspects of disease can be studied)
    > **Search first:** Model organism databases, PubMed
- **Resources**:
  - Model databases
    > **Search first:** MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

---

## Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic and clinical claims
- Prioritize recent reviews and landmark papers
- Include direct quotes from abstracts where possible to support key statements
- Distinguish evidence source types: human clinical, model organism, in vitro, computational

## Output Format

Structure your response as a comprehensive narrative organized by the sections above.
For each section, provide:
- Factual content with specific details (numbers, percentages, gene names, variant nomenclature)
- Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable
- Evidence citations with PMIDs
- Direct quotes from abstracts to support key claims
- Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with:
- Pathophysiology descriptions with causal chains
- Gene/protein annotations (HGNC, GO terms)
- Phenotype associations (HP terms) with frequencies
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Treatment annotations (NCIT terms)
- Evidence items with PMIDs and exact abstract quotes
- Epidemiology, prognosis, diagnostic, and prevention information
- Animal model descriptions with phenotype recapitulation details


## Output

I'm trying to confirm the PMIDs and abstract quotes for the SSX1 papers. Direct fetches are blocked, so I'm running more searches.

# Research report: Spermatogenic Failure, X-linked, 5 (SPGFX5), causal gene SSX1

**Verification status.** I could read only search-result summaries. Direct fetches of PubMed, PMC and ScienceDirect were refused by the proxy. These items are therefore unverified:
- No PMIDs were confirmed. Papers are cited by DOI or PMC ID only.
- No quote below is an exact, verified abstract snippet. Treat the quoted fragments as leads and re-fetch them with `just fetch-reference` before using them as evidence.
- Variant details beyond what is listed under section 4 are not verified.
- I did not confirm the MONDO ID `MONDO:0859477` given in the template.
- Nothing below was checked against the repository or run through its validators.

## 1. Disease information

SPGFX5 is an X-linked male infertility disorder caused by hemizygous loss-of-function variants in **SSX1** (SSX family member 1, Xp11.23, OMIM *312820). The phenotype is asthenoteratozoospermia, which means reduced or absent progressive sperm motility together with abnormal sperm morphology, including flagellar defects reported as consistent with multiple morphologic abnormalities of the sperm flagella (MMAF) ([MalaCards](https://www.malacards.org/card/spermatogenic_failure_x_linked_5); [OMIM SSX1](https://omim.org/entry/312820)).

- **Identifiers.** The disease entry is OMIM 301099, as given in the template and as shown on the mirrors I found ([MalaCards](https://malacards.org/card/spermatogenic_failure_x_linked_5)). Other mirrors are [GTR C5829558](https://https.ncbi.nlm.nih.gov/gtr/conditions/C5829558), [DOID:0070596](https://disease-ontology.org/term/DOID:0070596/owl) and [MedGen 1840194](https://ncbi.nlm.nih.gov/medgen/1840194).
- **Synonyms.** SPGFX5, SSX1-related asthenoteratozoospermia. SSX1 is also called CT5.1 and SSRC.
- **Data source.** The disease-level description rests on one cohort study of individual patients (Liu et al. 2023) and a small number of follow-up reports. It is not drawn from aggregated or EHR data.
- **Gene context.** SSX1 is better known for the t(X;18) SS18-SSX1 fusion in synovial sarcoma. That is a separate somatic cancer biology, and the two should not be conflated ([GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSX1)).
- **Gene name check.** The disease name does not name the gene, so confirm it. SSX1 is the correct gene for SPGFX5.

## 2. Etiology

- **Causal factor.** Hemizygous deleterious SSX1 variants in 46,XY men.
- **Risk and protective factors.** I found no data on genetic modifiers, environmental risk factors, protective factors or gene–environment interactions. Mark these as not available.

## 3. Phenotypes

All figures come from the six-man series in Liu et al. 2023. Per-patient frequencies and HPO annotations were not retrievable, so confirm them against Table 1 of the paper.

| Phenotype | Suggested HPO term |
|---|---|
| Asthenozoospermia (reduced progressive motility) | HP:0012206 |
| Teratozoospermia, including flagellar morphology defects (MMAF-like) | HP:0012864 |
| Male infertility | HP:0003251 |

I did not retrieve these HPO IDs from a lookup, so verify them before binding.

- **Onset and course.** Onset is in adulthood and is detected by infertility. It is presumably stable, but progression has not been reported.
- **Other systems.** I found no reported syndromic features.
- **Quality of life.** No data.

## 4. Genetic and molecular information

- **Cohort.** Liu et al. screened 536 Chinese men with asthenoteratozoospermia and found six unrelated men with hemizygous SSX1 variants. The paper is Am J Hum Genet 2023;110(3):516–530, [doi:10.1016/j.ajhg.2023.01.016](https://pmc.ncbi.nlm.nih.gov/articles/PMC10027476/). The finding is also summarized in [OMIM](https://omim.org/entry/312820).
- **Variants.**
  - One reported variant is c.164A>G (p.Tyr55Cys) in family Y1642. Four in-silico predictors (PolyPhen-2, SIFT, CADD, PROVEAN) rate it deleterious.
  - Other variants include a 2-bp deletion and a splice-site variant in the C-terminal SSXRD domain, listed as pathogenic in ClinVar without assertion criteria ([VCV002444463](https://www.ncbi.nlm.nih.gov/clinvar/variation/2444463/?new_evidence=true), [VCV002444464](https://www.ncbi.nlm.nih.gov/clinvar/variation/2444464/?new_evidence=true), [VCV002444465](https://www.ncbi.nlm.nih.gov/clinvar/variation/2444465/?new_evidence=true)).
  - One search summary says the variants include premature stops predicted to cause nonsense-mediated decay. I could not confirm this per variant.
- **Replication.** A 2026 whole-genome study reported a hemizygous SSX1 splice-donor variant (c.\*4+1G>T) in one man with oligoasthenoteratozoospermia, alongside variants in CPNE1 and SPTBN5 ([PubMed 42467186](https://pubmed.ncbi.nlm.nih.gov/42467186/); [Springer](https://link.springer.com/article/10.1007/s13353-026-01089-0)). It is a single case in a multi-gene study.
- **Expression.** SSX1 expression was significantly reduced in spermatozoa from affected men.
- **Functional consequence.** Loss of function. There is no evidence for dominant-negative or gain-of-function effects.
- **Origin.** Germline.
- **Gene-disease validity.** I found no ClinGen or GenCC classification. Per the repository's rules, leave `gene_disease_validity` absent rather than assigning a tier.
- **Modifiers, epigenetics, chromosomal abnormalities.** No data.

## 5. Environmental information

No environmental, lifestyle or infectious contributors are reported.

## 6. Mechanism and pathophysiology

**Causal chain, with demonstrated and inferred steps marked:**

1. Hemizygous loss-of-function variant in X-linked SSX1 in a 46,XY man. *Demonstrated.*
2. This leads to markedly reduced SSX1 expression in spermatozoa. *Demonstrated in patient sperm.*
3. This results in impaired spermatogenesis and sperm differentiation. RNA-seq in the animal models suggested SSX1 deficiency affects multiple spermatogenic processes, but I could not retrieve the details. *Inferred.*
4. This leads to abnormal sperm flagellar and head morphology. *Reported.*
5. This results in reduced progressive motility (asthenoteratozoospermia) and male infertility. *Reported.*
6. In the model species, Ssx1 knockdown reproduced the reduced motility and abnormal morphology. *Demonstrated in non-human primates and tree shrews.*

**Protein, pathways and ontology terms.**
- SSX1 is a primate-specific, cancer-testis-family protein. Its specific molecular function and interaction partners in sperm are not established here.
- Candidate GO terms are spermatogenesis (GO:0007283), sperm flagellum assembly and sperm motility. Verify these before use.
- Suggested cell types are spermatid (CL:0000018) and spermatozoon (CL:0000019), with the testis and seminiferous tubule (UBERON) as the tissue site.

**Omics and other mechanism categories.** I did not retrieve single-cell, proteomic or metabolomic data. Immune involvement, metabolic changes and tissue-damage mechanisms are not reported.

## 7. Anatomical structures affected

- **Organ and tissue.** The testis and the seminiferous epithelium, specifically germ cell differentiation.
- **Subcellular.** The sperm flagellum, and probably the head as well. Confirm the subcellular localization of SSX1 from the paper.
- **Lateralization.** Not applicable.

## 8. Temporal development

Onset is in adulthood, presenting as infertility. Course and critical periods are not described.

## 9. Inheritance and population

- **Inheritance.** X-linked. Males are hemizygous. Carrier mothers are presumed, but I could not confirm this.
- **Population.** The discovery cohort was Chinese. Prevalence, incidence, founder effects, penetrance, carrier frequency and consanguinity role are unknown.
- **Sex.** Affects males only.

## 10. Diagnostics

- **Semen analysis.** It shows reduced progressive motility plus abnormal morphology, and sperm morphology studies show flagellar abnormalities.
- **Genetics.** Exome sequencing identified the cases. A gene panel for asthenoteratozoospermia or male infertility should include SSX1.
- **Differential diagnosis.** Other single-gene causes of MMAF and asthenoteratozoospermia, such as DNAH1 and CFAP-family genes. Another X-linked cause is USP26 ([PMC8307012](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307012/)).
- **Not applicable or not available.** There are no known biomarkers, imaging findings or biopsy features specific to SPGFX5. Newborn and population screening do not apply.

## 11. Outcome and prognosis

The condition is lifelong male infertility. Reproductive prognosis with assisted reproduction is favorable but not guaranteed. Survival and other complications have not been reported.

## 12. Treatment

- **ICSI** (intracytoplasmic sperm injection) is the only reported option. Five of the six men received ICSI, and the authors concluded it is favorable for SSX1-associated asthenoteratozoospermia ([PMC10027476](https://pmc.ncbi.nlm.nih.gov/articles/PMC10027476/); [MalaCards](https://www.malacards.org/card/spermatogenic_failure_x_linked_5)). Some couples did not achieve a pregnancy, and the authors partly attributed this to paternal age, oocyte quality or other factors. I could not retrieve per-couple outcomes.
- **Suggested NCIT terms.** Use a procedure term for assisted reproduction, but only after a lookup. The repository forbids writing NCIT IDs from memory.
- **Other therapies.** There are no gene therapies, drugs or clinical trials known to me, and no pharmacogenomics data.

## 13. Prevention

- **Genetic counseling.** Because the inheritance is X-linked, a male patient's daughters would be obligate carriers. His sons would not inherit his X chromosome. Carrier mothers can pass the variant to sons. This is general X-linked reasoning, not a finding from the paper.
- **Other prevention.** No primary prevention exists. Prenatal testing or preimplantation genetic testing is possible in principle.

## 14. Other species and natural disease

I found no OMIA entry or naturally occurring disease. SSX1 is described as primate-specific, so a rodent ortholog may be absent. Confirm this against the paper before relying on it.

## 15. Model organisms

- **Cynomolgus monkey** (*Macaca fascicularis*, NCBITaxon:9541) and **tree shrew** (*Tupaia belangeri*, NCBITaxon:37347).
  - These are Ssx1 knockdown models made with AAV9 vectors delivered into the seminiferous tubules.
  - Both reproduced reduced sperm motility and abnormal morphology ([ScienceDirect](https://www.sciencedirect.com/science/article/pii/S0002929723000162)).
  - They are knockdowns, not germline knockouts, and a knockdown is partial and may be transient.
  - Evidence from these models is `MODEL_ORGANISM`. In the schema, link them with `modeled_mechanisms` and record the knockdown limitation.
- **Mouse.** I found no useful mouse model. The International Mouse Phenotyping Consortium (IMPC) page for the mouse Ssx1 locus, MGI:107698, exists but I did not read it.

## Gaps to close before curating

1. Fetch the Liu et al. 2023 abstract and Table 1 with `just fetch-reference`. That gives the PMID, the per-patient variants and phenotypes, and the ICSI outcomes.
2. Look up every HPO, GO and CL ID with the repository's term tools.
3. Verify the MONDO ID.
4. Check ClinGen and GenCC for a gene-disease validity classification.

Sources:
- [MalaCards: Spermatogenic Failure, X-Linked, 5](https://www.malacards.org/card/spermatogenic_failure_x_linked_5)
- [OMIM *312820 SSX1](https://omim.org/entry/312820)
- [Liu et al. 2023, AJHG, via PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC10027476/)
- [Liu et al. 2023, via ScienceDirect](https://www.sciencedirect.com/science/article/pii/S0002929723000162)
- [SSX1, CPNE1 and SPTBN5 whole-genome study, PubMed](https://pubmed.ncbi.nlm.nih.gov/42467186/)
- [Same study, Springer](https://link.springer.com/article/10.1007/s13353-026-01089-0)
- [ClinVar VCV002444463](https://www.ncbi.nlm.nih.gov/clinvar/variation/2444463/?new_evidence=true)
- [ClinVar VCV002444464](https://www.ncbi.nlm.nih.gov/clinvar/variation/2444464/?new_evidence=true)
- [ClinVar VCV002444465](https://www.ncbi.nlm.nih.gov/clinvar/variation/2444465/?new_evidence=true)
- [GeneCards SSX1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSX1)
- [MalaCards (alternate URL)](https://malacards.org/card/spermatogenic_failure_x_linked_5)
- [Disease Ontology DOID:0070596](https://disease-ontology.org/term/DOID:0070596/owl)
- [GTR C5829558](https://https.ncbi.nlm.nih.gov/gtr/conditions/C5829558)
- [MedGen 1840194](https://ncbi.nlm.nih.gov/medgen/1840194)
- [USP26 asthenoteratozoospermia, PMC8307012](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307012/)

## Reference Validation

Checked with `linkml-reference-validator` 0.3.0.

| Outcome | Count |
| --- | --- |
| References checked | 5 |
| Resolved | 3 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 2 |
| References weighed for topical relevance | 3 |
| On topic | 2 |
| Off topic | 0 |

3 of 5 references resolved; the rest could not be looked up either way.

## Term Validation

Checked with `linkml-term-validator` 0.4.5, through the `ols:` adapter.

| Outcome | Count |
| --- | --- |
| Terms checked | 11 |
| Resolved | 10 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 1 |
| Terms whose name was checked | 5 |
| Terms named correctly | 1 |
| Terms named as a **different** term | 3 |
| Terms whose name is worth a second look | 1 |

### Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

- `HP:0012206` (1 mention) - the report calls it "Asthenozoospermia (reduced progressive motility)"; HP calls it **Abnormal sperm motility**
- `HP:0012864` (1 mention) - the report calls it "Teratozoospermia, including flagellar morphology defects (MMAF-like)"; HP calls it **Abnormal sperm morphology**
- `CL:0000018` (1 mention) - the report calls it "Suggested cell types are spermatid"; CL calls it **spermatid**

### Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a *related* synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

- `GO:0007283` (1 mention) - the report calls it "Candidate GO terms are spermatogenesis"; GO calls it **spermatogenesis**

### Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: `MGI`.